BIOA
BioAge Labs, Inc.
NASDAQ · Healthcare · Biotechnology · US
$8.06
−0.37%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 117.50x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.99x
- Price / sales
- 35.72x
- Price / cash flow
- -4.22x
Enterprise value
- Enterprise value
- $54.0M
- EV / sales
- 5.22x
- EV / EBITDA
- -0.58x
- EV / EBIT
- -0.51x
- Market cap
- $369.9M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026